Disease Context and Longevity Genes Project. Many genetically-mediated factors contributing to longevity are likely to impact disease processes in addition to some fundamental mechanism of aging and/or senescence. We believe that an understanding of how much overlap there might be between genetic variants that impact disease susceptibility, as well as disease-related processes, and genetic variants that uniquely impact longevity can be obtained by pursuing genetic association studies with large data sets made up of individuals with different diseases and individuals that have lived an exceptionally long and healthy life. We will obtain as many relevant data sets with genotype and sequencing data as possible from resources such as dbGAP and combine them with unique Longevity Consortium (LC) data sets for different types of analyses. This will lead to unprecedentedly large combined data sets with excellent statistical power, amenable to either mega (i.e., combined raw data) and meta (i.e., only using summary statistics) data analyses. Relevant analyses can involve direct association testing or Mendelian Randomization (MR) testing leveraging imputed intermediate phenotypes for causality analysis, but will have to accommodate a harmonization of phenotypes, control for population stratification, as well as potential heterogeneity in genetic effects. Tools for dealing with phenotypic harmonization with be developed and applied, as will analytical methods for handling stratification and heterogeneity. In fact, the development and implementation of analytical methods that accommodate heterogeneity will be a main feature of the proposed research. We emphasize that all findings from other LC investigators will be tested in the proposed analyses, either directly if a genetic variant (e.g., arising from the Perls-Centenarians project), via orthology for genes arising from the Miller-Mice/Cells project that may harbor interesting human genetic variants, or via imputation, where possible, as an intermediate phenotype (e.g., as a protein arising from the Orwoll-Proteomics or metabolite from the Fiehn-Metabolomics projects) amenable to MR tests. In addition, all factors found to be of interest from the proposed analyses will also be provided to the other investigators as well as the Price-Systems Biology and Girke-Chemoinformatics cores for further and integrated analyses. We emphasize that the proposed analyses can be pursued in a wide variety of ways to yield previously undocumented insights. For example, if diabetes and obesity share genetic determinants, then combining individuals with diabetes and obesity and comparing them to individuals who have lived a long life without diabetes or obesity should reveal genetic factors mediating general vulnerabilities to metabolic diseases in all or a subset of individuals with unprecedented power.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AG023122-11A1
Application #
9632492
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-09-30
Budget End
2019-05-31
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
California Pacific Medical Center Research Institute
Department
Type
DUNS #
071882724
City
San Francisco
State
CA
Country
United States
Zip Code
94107
Brown, Abigail K; Webb, Ashley E (2018) Regulation of FOXO Factors in Mammalian Cells. Curr Top Dev Biol 127:165-192
Zeng, Yi; Nie, Chao; Min, Junxia et al. (2018) Sex Differences in Genetic Associations With Longevity. JAMA Netw Open 1:
Schork, Nicholas J; Raghavachari, Nalini; Workshop Speakers and Participants (2018) Report: NIA workshop on translating genetic variants associated with longevity into drug targets. Geroscience 40:523-538
Ding, Kuan-Fu; Finlay, Darren; Yin, Hongwei et al. (2018) Network Rewiring in Cancer: Applications to Melanoma Cell Lines and the Cancer Genome Atlas Patients. Front Genet 9:228
Ding, Kuan-Fu; Petricoin, Emanuel F; Finlay, Darren et al. (2018) Nonlinear mixed effects dose response modeling in high throughput drug screens: application to melanoma cell line analysis. Oncotarget 9:5044-5057
Perls, Thomas T (2017) Male Centenarians: How and Why Are They Different from Their Female Counterparts? J Am Geriatr Soc 65:1904-1906
Pickering, Andrew M; Lehr, Marcus; Gendron, Christi M et al. (2017) Mitochondrial thioredoxin reductase 2 is elevated in long-lived primate as well as rodent species and extends fly mean lifespan. Aging Cell 16:683-692
Ding, Kuan-Fu; Finlay, Darren; Yin, Hongwei et al. (2017) Analysis of variability in high throughput screening data: applications to melanoma cell lines and drug responses. Oncotarget 8:27786-27799
Sebastiani, Paola; Bae, Harold; Gurinovich, Anastasia et al. (2017) Limitations and risks of meta-analyses of longevity studies. Mech Ageing Dev 165:139-146
Sebastiani, Paola; Thyagarajan, Bharat; Sun, Fangui et al. (2017) Biomarker signatures of aging. Aging Cell 16:329-338

Showing the most recent 10 out of 202 publications